Juan-Andres Rivera Ramirez, MD

Regulation of somatostatin and its receptors (SSTR), as an antiproliferative system in cancer. Therapeutic implications. Emphasis on Breast Cancer. Expression of the SSTR in carcinoid and other neuroendocrine tumors, correlation with malignant behavior and implications for the use of specific SST analogs. Development of clinical and radiological criteria for diagnosis of lymphocytic hypophysitis in all its variants.